| ［1］ Peate M, Meiser B, Cheah BC, et al. Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertilityrelated decision aid in young women with earlystage breast cancer［J］. Br J Cancer， 2012， 106 (6): 1053-1061. ［2］ Hill KA, Nadler T, Mandel R， et al. Experience of young women diagnosed with breast cancer who undergo fertility preservation consultation［J］. Clin Breast Cancer, 2012， 12(2): 127-132. ［3］ Corney RH, Swinglehurst AJ. Young childless women with breast cancer in the UK: a qualitative study of their fertilityrelated experiences, options, and the information given by health professionals［J］. Psychooncology， 2013， In press. ［4］ Swain SM, Jeong JH, Geyer CE Jr, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer［J］. N Engl J Med, 2010， 362(22): 2053-2065. ［5］ Kroman N, Jensen MB, Wohlfahrt J, et al. Pregnancy after treatment of breast cancer—a populationbased study on behalf of Danish Breast Cancer Cooperative Group［J］. Acta Oncol, 2008, 47(4): 545-549. ［6］ Azim HA Jr, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: a metaanalysis of 14 studies［J］. Eur J Cancer, 2011， 47(1): 7483. ［7］ Largillier R, Savignoni A, Gligorov J, et al. Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged< 35 years: a CET(N)A Working Group analysis［J］. Cancer, 2009， 115(22): 5155-5165. ［8］ Sukumvanich P, Case LD, Van Zee K, et al. Incidence and time course of bleeding after longterm amenorrhea after breast cancer treatment: a prospective study［J］. Cancer, 2010， 116(3): 3102-3111. ［9］ Christinat A, Pagani O. Fertility after breast cancer［J］. Maturitas， 2012， 73(3): 191-196. ［10］ Christinat A, Di Lascio S, Pagani O. Hormonal therapies in young breast cancer patients: when, what and for how long? ［J］. J Thorac Dis， 2013， 5 Suppl 1: S36-46. ［11］ Oktay K, Türküoˇglu I, RodriguezWallberg KA, et al. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation［J］. Reprod Biomed Online， 2010， 20(6): 783-788. ［12］ Das M, Shehata F, Son WY, et al. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy［J］. Hum Reprod， 2012， 27(8): 2509-2514. ［13］ Balber AE. Concise review: aldehyde dehydrogenase bright stem and progenitor cell populations from normal tissues: characteristics, activities, and emerging uses in regenerative medicine［J］. Stem Cell, 2011， 29(4): 570-575. ［14］ Pagani O, Partridge A, Korde L, et al. Pregnancy after breast cancer: if you wish, ma′am［J］. Breast Cancer Res Treat， 2011， 129(2): 309-317. |
